Galapagos Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Henry Gosebruch

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure2.4yrs
Board average tenure1.9yrs

Recent management updates

Recent updates

Disount To Net Cash For A Promising CAR-T Company

Feb 20

Galapagos Struggles To Carve A Path In A Crowded CAR-T Therapy Market

Dec 14

Galapagos: CAR-T Biotech To Change Landscape With GLPG5101 And Beyond

Aug 23

Galapagos: Pipeline Still Progressing Despite Financial Volatility

Mar 07

Galapagos: Trading At Discount To Cash With A Fast-Growing Marketed Product

Oct 10

EMA panel approves amending label for Galapagos' Jyseleca on testicular function effects

Oct 03

Galapagos stock dips after Jefferies slashes rating citing challenges ahead

Jul 25

Galapagos: Can The Company Turn Around?

May 19

Galapagos: A History Of Disruptive Failures

Feb 22

Galapagos: The Investment Thesis Is More Appealing Than Ever

Dec 02

CEO

Henry Gosebruch

no data

Tenure

Mr. Henry Gosebruch is CEO & Executive Director of Galapagos NV from May 13, 2025. He serves as Founding CEO of SpinCo since April 21, 2025.


Leadership Team

NamePositionTenureCompensationOwnership
Henry Gosebruch
CEO & Executive Directorno datano datano data
Thad Huston
Executive VP1.8yrsno datano data
Valeria Cnossen
Executive VP & General Counsel3.3yrsno datano data
Marieke Vermeersch
Head of Corporate Communicationno datano datano data
Annelies Missotten
Executive VP & Chief Human Resources Officerno datano datano data
Ellen Aar
Head of Developmentno datano datano data
Philippe Alen
Senior VP & Head of Business Development3.3yrsno datano data
Alice Dietrich
Head of Medical Affairsno datano datano data
Pierre Raboisson
Head of Small Molecules Discovery & Senior VP2.9yrsno datano data
Patrik Ringblom
Head of Strategy & US Lead1.6yrsno datano data
Jeevan Shetty
Head of Clinical Development Oncologyno datano datano data
Ruiz Astigarraga
Head of Manufacturing Cell Therapyno datano datano data

2.4yrs

Average Tenure

51yo

Average Age

Experienced Management: GLPG's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Henry Gosebruch
CEO & Executive Directorno datano datano data
Simon Sturge
Independent Non-Executive Director1.7yrs€133.33k0.0017%
$ 30.1k
Jerome Contamine
Lead Independent Non-Executive Director & Chairman3.1yrs€184.60k0.0033%
$ 59.0k
Andrew Dickinson
Non-Executive Non-Independent Director1.2yrsno datano data
Linda Higgins
Non-Executive Non-Independent Director5.6yrsno datano data
Susanne Schaffert
Non-Executive Independent Director1.9yrs€123.50k0.0019%
$ 35.0k
Oleg Nodelman
Non-Executive Non-Independent Directorless than a yearno datano data
Peter Guenter
Independent Non-Executive Director6.1yrs€122.61k0.0044%
$ 79.4k
Elisabeth Svanberg
Independent Non-Executive Director5.1yrs€162.60k0.0043%
$ 76.2k

1.9yrs

Average Tenure

62yo

Average Age

Experienced Board: GLPG's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 11:19
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Galapagos NV is covered by 32 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
René VerhoefABN AMRO Bank N.V.
Emily FieldBarclays
Xue ChenBarclays